House of Lords Business
Show full summary

Lord Warner to ask His Majesty's Government what is the evidence that the Department of Health and Social Care used to support the statement in the consultation on the Statutory Scheme to control the cost of branded health services medicines that investment in research and development in the UK was not a "net benefit".  HL10592

Question HL10592: tabled on 16 October 2023 and due for answer by 30 October 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Warner to ask His Majesty's Government what is the evidence that the Department of Health and Social Care used to support the statement in the consultation on the Statutory Scheme to control the cost of branded health services medicines that investment in research and development in the UK was not a "net benefit".  HL10592
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Warner
Crossbench
Life peer